Contrast dye to improve heart ultrasound images
Part of Heart & circulation clinical trials.
This trial tests a new contrast agent called NH002 that may help doctors see your heart more clearly on an ultrasound. It could be an option if your previous heart ultrasound images were not clear enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have or might have heart disease.
- You had a heart ultrasound within the last 30 days, but the images were not clear enough to see all parts of your heart.
- You are not pregnant or breastfeeding.
- You have not had a reaction to contrast agents or polyethylene glycol (PEG) before.
- You have not taken part in another investigational drug study within the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving Lumason (an ultrasound contrast agent) to improve images of the left ventricle in people whose initial heart ultrasound was unclear. It may help those with a 'suboptimal' view of the heart's pumping chamber.
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
This trial studies whether a newer, faster ultrasound imaging method can better assess areas of the heart that may not get enough blood during stress. You may be eligible if you have known coronary artery disease or are considered low risk, and if you can safely undergo the stress ultrasound test.
This study tests whether a 3D ultrasound of the heart gives better information than a standard 2D ultrasound in people with heart failure. It aims to improve how doctors measure heart function, which could help guide treatment.
This study uses a special ultrasound (echocardiography) with a contrast dye to see how blood flows through your lungs during exercise. It aims to help doctors better understand why patients get short of breath during activity.
This study tests a new way to use ultrasound with a contrast agent to see if parts of the heart aren't getting enough blood flow (ischemia) in people who might be having a heart attack. It could help doctors diagnose and treat heart issues more quickly.
Hear when a new Cardiac Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.